Logo image of NXE

NEXGEN ENERGY LTD (NXE) Stock Fundamental Analysis

NYSE:NXE - New York Stock Exchange, Inc. - CA65340P1062 - Common Stock - Currency: USD

6.77  +0.09 (+1.35%)

After market: 6.7708 +0 (+0.01%)

Fundamental Rating

2

NXE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. NXE has a bad profitability rating. Also its financial health evaluation is rather negative. NXE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NXE has reported negative net income.
In the past year NXE has reported a negative cash flow from operations.
In the past 5 years NXE reported 4 times negative net income.
In the past 5 years NXE always reported negative operating cash flow.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -5.99%, NXE is not doing good in the industry: 78.87% of the companies in the same industry are doing better.
NXE's Return On Equity of -8.51% is on the low side compared to the rest of the industry. NXE is outperformed by 73.24% of its industry peers.
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NXE has been increased compared to 1 year ago.
NXE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NXE is higher compared to a year ago.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.36 indicates that NXE is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.36, NXE belongs to the top of the industry, outperforming 91.08% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that NXE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, NXE belongs to the best of the industry, outperforming 83.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.36
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NXE has a Current Ratio of 0.97. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.97, NXE is in line with its industry, outperforming 40.85% of the companies in the same industry.
A Quick Ratio of 0.97 indicates that NXE may have some problems paying its short term obligations.
The Quick ratio of NXE (0.97) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

NXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.52%, which is quite impressive.
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 2.55% on average over the next years.
NXE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 210.01% yearly.
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.55%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.01%

3.3 Evolution

NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2028 2029 2030 2031 2032 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as NXE's earnings are expected to decrease with -2.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.51%
EPS Next 3Y-2.19%

More info and screens

0

5. Dividend

5.1 Amount

NXE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

NYSE:NXE (6/24/2025, 8:04:00 PM)

After market: 6.7708 +0 (+0.01%)

6.77

+0.09 (+1.35%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners54.47%
Inst Owner Change7.61%
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap3.86B
Analysts81.11
Price Target9.92 (46.53%)
Short Float %15.07%
Short Ratio7.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.07%
Min EPS beat(2)-159.31%
Max EPS beat(2)241.44%
EPS beat(4)3
Avg EPS beat(4)46.25%
Min EPS beat(4)-159.31%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-51.8%
EPS beat(12)4
Avg EPS beat(12)-131.16%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.17%
PT rev (3m)-0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.94%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.82
P/tB 4.82
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS1.4
TBVpS1.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5461.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 6.36
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.01%
EBIT growth 1Y45.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.72%
EBIT Next 3Y3.55%
EBIT Next 5Y9.69%
FCF growth 1Y-41.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.5%
OCF growth 3YN/A
OCF growth 5YN/A